Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
Nenhuma Miniatura disponível
Data
2009-04-01
Autores
Narciso-Schiavon, Janaina L. [UNIFESP]
Freire, Fernanda Caruso F. [UNIFESP]
Suarez, Marcelo Mendes [UNIFESP]
Ferrari, Marcus Vinicius O. [UNIFESP]
Scanhola, Gustavo Quirino [UNIFESP]
Schiavon, Leonardo de Lucca [UNIFESP]
Carvalho Filho, Roberto J. de [UNIFESP]
Ferraz, Maria Lucia G. [UNIFESP]
Silva, Antonio Eduardo B. [UNIFESP]
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Background Serum autoantibodies such as antinuclear antibody (ANA) are frequently detected in patients with chronic hepatitis C virus (HCV) infection, but its relevance is a matter of discussion.Aim To assess the association of ANA positivity with clinical and histological features, and with the outcome of antiviral therapy in patients with HCV infection.Methods Baseline samples from patients with hepatitis C treated with interferon and ribavirin were tested for ANA positivity by indirect immunofluorescence.Results the mean age was 48.3 +/- 11.1 years and 56% were men. Among 234 included patients, 22 patients (9.4%) were positive for ANA. These patients showed significantly higher median alanine aminotransferase level (3.52 vs. 2.39 x upper limit of normal, P=0.009) when compared with ANA-negative patients. Fibrosis stage and necroinflammatory grading were not influenced by ANA positivity. Sustained virological response (SVR) rates were similar between ANA-positive and ANA-negative patients (27 vs. 29%, P=0.882). Alanine aminotransferase flares (>= 1.5-fold the baseline) during treatment were observed in 28 patients (12%), irrespective of the presence of ANA and without any clinical significance.Conclusion Among HCV patients, ANA positivity seems to represent an immunological epiphenomenon. It neither influences clinical, biochemical, and histological features of chronic hepatitis C nor predicts response to antiviral treatment. Eur J Gastroenterol Hepatol 21:350-356 (C) 2009 Wolters Kluwer Health / Lippincott Williams & Wilkins.
Descrição
Citação
European Journal of Gastroenterology & Hepatology. Philadelphia: Lippincott Williams & Wilkins, v. 21, n. 4, p. 350-356, 2009.